| Adverse effects: 8. sleep ‐ skewed data ‐ average change score (UKU) ‐ short term (up to 12 weeks) | ||||
|---|---|---|---|---|
| Study | Intervention | Mean | SD | N |
| Yagcioglu 2005 | Risperidone | 0.7 | 0.36 | 16 |
| Yagcioglu 2005 | Placebo | 0.2 | 0.37 | 14 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.